SBEV
Endovia Health Sciences, Inc.Price
Daily candles with volume.
Signal stack
Where each data set points today.
- InsidersNO TRADES
No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
- InstitutionsMIXED
Q2 2026: 1 added (0 new), 1 trimmed or exited.
- Short sellersCOVERING
Short interest −56.1% to 464.4K shares. 1.0 days to cover, ≈7.2% of shares.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| TRUIST FINANCIAL CORP | DOUBLED | $10.5K |
| HRT FINANCIAL LP | TRIM | $8.0K |
| HRT FINANCIAL LP | DOUBLED | $48.0K |
| GEODE CAPITAL MANAGEMENT, LLC | DOUBLED | $20.6K |
| UBS Group AG | DOUBLED | $19.1K |
| HRT FINANCIAL LP | ADD | $16.0K |
| UBS Group AG | DOUBLED | $10.4K |
| VANGUARD GROUP INC | TRIM | $7.6K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
last action Nov 2024| Date | Firm | Rating |
|---|---|---|
| Nov 29, 2024 | HC Wainwright & Co. MAINTAIN | Buy |
| Sep 3, 2024 | Roth MKM MAINTAIN | Buy |
| Aug 26, 2024 | HC Wainwright & Co. REITERATE | Buy |
| Jun 25, 2024 | Roth MKM MAINTAIN | Buy |
| May 22, 2024 | HC Wainwright & Co. REITERATE | Buy |
| Apr 4, 2024 | HC Wainwright & Co. MAINTAIN | Buy |
Insider ledger
Form 4| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 8, 2026 | Cobb Brady James Interim CEO | AWARD | 925,000 sh |
| Jun 8, 2026 | Scott Martin P Interim CFO | AWARD | 700,000 sh |
| Jun 8, 2026 | Caple Frederick William Director | AWARD | 500,000 sh |
| Jun 8, 2026 | Francis Knuettel II Director | AWARD | 500,000 sh |
| Jun 8, 2026 | Fore Thomas Butler Director | AWARD | 500,000 sh |
| Jun 8, 2026 | Bondurant Michael Breen Chief Operating Officer | AWARD | 800,000 sh |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Aug 14, 2026| Jul 16, 2026 | Resumption Scheduled | Resumed |
SecBot reports
14 filings · 1 press release · 1 bullish · 4 bearish · 1 mixed · 8 neutral- NEUTRAL DEFA14AOct 7, 2026
Endovia Health Sciences filed a DEFA14A correcting a scrivener's error in the record date for its…
Monitor the November 20 Annual Meeting for vote outcomes on the equity plan amendments and RSU grants, which could increase share count and dilute existing holders. No immediate trading catalyst…
- NEUTRAL 8-KAug 25, 2026
Endovia Health Sciences (formerly Splash Beverage Group) announced that the FDA's Center for…
This is an early-stage regulatory milestone with no financial data — the stock has historically been highly volatile on news. Monitor for future development milestones, capital raises (the company's…
- NEUTRAL 8-KAug 21, 2026
Splash Beverage Group (SBEV) announced it will change its corporate name to Endovia Health…
This is a routine name/ticker change filing with no financial data. Monitor for future 10-Q or 8-K filings that may contain financial results or operational milestones. The implied pivot to…
- NEUTRAL 8-KAug 20, 2026
Splash Beverage Group reported Q2 2026 results highlighting a 64% year-over-year reduction in loss…
The filing lacks hard Q2 2026 financials (revenue, EPS), making a fundamental earnings read impossible. The strategic pivot to cannabinoid health sciences is a high-risk, long-duration catalyst with…
All SBEV filing & press-release reports (15)
- DEFA14A reportOct 7, 2026
- 8-K reportAug 25, 2026
- 8-K reportAug 21, 2026
- 8-K reportAug 20, 2026
- 8-K reportAug 12, 2026
- S-1 reportAug 7, 2026
- 8-K reportAug 5, 2026
- 8-K reportJul 14, 2026
- 8-K reportJul 9, 2026
- 8-K reportJul 6, 2026
- 8-K reportJun 26, 2026
- EFFECT reportJun 23, 2026
- 8-K reportJun 15, 2026
- PRESS-RELEASE reportMay 5, 2026
- 8-K reportMar 5, 2026